Skip to main content
. Author manuscript; available in PMC: 2009 May 1.
Published in final edited form as: Ann Biomed Eng. 2008 Feb 14;36(5):821–830. doi: 10.1007/s10439-008-9444-9

FIGURE 4.

FIGURE 4

NIR imaging of in vivo scFv biodistribution at 4 h post-injection. (a) Specific targeting was seen with scFv 10A to the tumor treated with 6 Gy (left leg) as compared to untreated tumor (right leg) and the rest of the body as early as 4 h post-injection. (b) No tumor-specific binding seen with mice treated with scFv 4A.